Effect of enema with Mahatiktaka Ghrita in the management of Heavy Menstrual Bleeding.

Effect of Matravasti with Mahatiktaka Ghrita in Heavy Menstrual Bleeding. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104048

Enrollment

Registered

2026-02-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Females of age 18-50 years. Subjects with menstrual bleeding for more than 7 days and/or excessive in amount for the last two consecutive menstrual cycles. Excessive bleeding during menstruation having a PBLAC score of more than 100 points.

Exclusion criteria

Exclusion criteria: Bleeding associated with pregnancy or miscarriage Subjects undergoing hormonal replacement therapy Hb level less than or equal to 7 gm% Post-menopausal bleeding K/C/O Urogenital malignancy Women using IUCD/OCP Patient with uncontrolled Hypertension, Diabetes mellitus, Thyroid dysfunction Patients with known cases of Liver dysfunction, Congestive cardiac failure, Coagulation disorders, Tuberculosis, Venereal diseases and Malignant conditions.

Design outcomes

Primary

Measure	Time frame
To determine the effect of matravasti with mahatiktaka Ghrita in reducing the amount of bleeding in Heavy Menstrual BleedingTimepoint: Assessment of PBLAC score will be carried out on the 4th day of menstruation (pre assessment before intervention),8th day(intermediate) and on 10th day of menstruation (post assessment).	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactKALHARA J

PNNM AYURVEDA MEDICAL COLLEGE AND HOSPITAl CHERUTHURUTHY

salipkavungal@gmail.com7025130539

Outcome results